If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giovanni Battista Rossi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Adenomatous Polyposis Coli Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Hereditary Nonpolyposis Colorectal Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
Colonic Neoplasms Medicine & Life Sciences
APC Genes Medicine & Life Sciences
Multiple Hamartoma Syndrome Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2020

Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives

Genova, C., Rossi, G., Tagliamento, M., Rijavec, E., Biello, F., Cerbone, L., Zullo, L. & Grossi, F., Jan 1 2020, (Accepted/In press) In : Expert Review of Respiratory Medicine.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Epidermal Growth Factor Receptor
Antineoplastic Agents
Proto-Oncogenes
Expert Testimony

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer

Carbone, F., Grossi, F., Bonaventura, A., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Biello, F., Rossi, G., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., Oct 15 2019, In : Clinical and Experimental Metastasis. 36, 5, p. 449-456 8 p.

Research output: Contribution to journalArticle

Osteopontin
Non-Small Cell Lung Carcinoma
Serum
Therapeutics
C-Reactive Protein
Open Access
Non-Small Cell Lung Carcinoma
Microtubules
Tubulin Modulators
Vinca Alkaloids
Drug Therapy

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study

Bonaventura, A., Grossi, F., Carbone, F., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Rossi, G., Biello, F., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., Jan 1 2019, In : Cancer Immunology, Immunotherapy. 68, 8, p. 1351-1358

Research output: Contribution to journalArticle

Survival
Serum
nivolumab
Proprotein Convertase 9
ROC Curve

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

Tagliamento, M., Genova, C., Rijavec, E., Rossi, G., Biello, F., Dal Bello, M. G., Alama, A., Coco, S., Boccardo, S. & Grossi, F., Dec 12 2018, In : Expert Opinion on Pharmacotherapy. 19, 18, p. 2055-2062 8 p.

Research output: Contribution to journalReview article

Squamous Cell Neoplasms
Squamous Cell Carcinoma
Lung Neoplasms
Lung
Epidermal Growth Factor Receptor